Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Contineum Therapeutics In...

    NASDAQ: CTNM · Real-Time Price · USD
    7.36
    0.10 (1.38%)
    At close: Aug 15, 2025, 3:59 PM
    7.38
    0.27%
    After-hours: Aug 15, 2025, 04:10 PM EDT

    Contineum Therapeutics Class A Common Stock Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a n/a n/a 50M 50M 50M 50M n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a 42K 115K 196K 196K 154K 81K
    Gross Profit
    		 n/a n/a n/a n/a n/a 49.96M 49.88M 49.8M 49.8M -154K -81K
    Operating Income
    		 35.76M 42.71M 50.89M -43.52M -38.62M 11.26M 16.08M 20.3M 28.37M -10.56M -5.45M
    Interest Income
    		 9.55M 9.52M 8.91M 8.17M 7.16M 5.84M 4.61M 3.16M 1.42M 743K 342K
    Pretax Income
    		 -56.86M -49.83M -42.26M -35.62M -31.73M 19.58M 23.17M 23.59M 29.96M -12.34M -7.51M
    Net Income
    		 -56.86M -49.83M -42.26M -35.46M -31.45M 19.13M 22.72M 22.98M 29.23M -12.34M -7.51M
    Selling & General & Admin
    		 15.52M 14.72M 12.47M 10.11M 8.43M 6.99M 6.32M 6.36M 4.79M 3.19M 1.71M
    Research & Development
    		 50.52M 44.36M 38.42M 33.42M 30.19M 31.75M 27.6M 23.55M 17.05M 7.59M 3.95M
    Other Expenses
    		 -101.79M -101.79M -101.79M n/a n/a n/a n/a -10K -10K -10K -10K
    Operating Expenses
    		 -35.76M -42.71M -50.89M 43.52M 38.62M 38.74M 33.92M 29.61M 21.55M 10.48M 5.37M
    Interest Expense
    		 n/a n/a n/a n/a n/a 116K 208K 309K 309K 193K 101K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a 213K 213K 213K 213K
    Cost & Expenses
    		 -53.66M -42.71M -50.89M 43.52M 38.62M 38.74M 33.92M 29.7M 21.63M 10.56M 5.45M
    Income Tax Expense
    		 n/a n/a n/a -161K -279K 450K 450K 611K 729K n/a n/a
    Shares Outstanding (Basic)
    		 25.9M 25.87M 25.85M 25.73M 25.72M 25.72M 25.13M 25.43M 25.72M 25.72M 25.13M
    Shares Outstanding (Diluted)
    		 25.9M 25.87M 25.85M 25.73M 25.72M 25.72M 25.13M 25.43M 25.72M 25.72M 25.13M
    EPS (Basic)
    		 -2.29 -2.02 -1.73 -1.39 -1.24 0.73 0.87 0.88 1.13 -0.49 -0.3
    EPS (Diluted)
    		 -2.29 -2.02 -1.73 -1.39 -1.24 0.73 0.87 0.88 1.13 -0.49 -0.3
    EBITDA
    		 -60.63M -51.68M -43.51M -36.92M -33.04M 18.36M 23.57M 24.14M 30.46M -11.99M -7.33M
    EBIT
    		 -42.94M -51.95M -43.77M -37.14M -33.24M 18.18M 23.38M 23.9M 30.27M -12.14M -7.41M
    Depreciation & Amortization
    		 215K 275K 258K 220K 201K 183K 195K 239K 196K 154K 81K

    Add to Watchlist